Maryam Tabatabai, PharmD, vice president of clinical information, and Carole Kerzic, RPh, drug information pharmacist, share more about glucagon-like peptide-1 (GLP-1) receptor agonists in the drug...

Someone holds a GLP-1 pen needle in their hands.

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members

New resource page offers the latest GLP-1 insights, research and perspectives

New report details the latest on GLP-1s

Following real-world analysis of GLP-1 drugs for weight loss, Prime/Magellan Rx releases new video about GLP-1 research

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products

Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common GLP-1 fraud schemes